Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Occupational Exposure Risk on Reproduction/Development, Request for Applications (RFA) OH-05-003, 7113-7114 [05-2571]

Download as PDF 7113 Federal Register / Vol. 70, No. 27 / Thursday, February 10, 2005 / Notices all stages of life by making our food supply safe, identifying harmful behaviors, and improving our environment. CDC and the Agency for Toxic Substances and Disease Registry (ATSDR) must fulfill their mission and mandate to frequently communicate urgent and sensitive health messages with the general public, members of the public with certain diseases or disabling conditions, and those at a greater risk of exposure to disease or injury causing agents. CDC/ATSDR makes this crucial health information available through many channels including books, periodicals, and monographs; internet Web sites; health and safety guidelines; reports from investigations and emergency responses; public health monitoring and statistics; travel advisories; answers to public inquiries; and health education campaigns. In addition to serving the public, CDC/ATSDR delivers health information that enables health providers to make critical decisions. For instance, the practicing medical and dental communities and the nation’s health care providers are target audiences for numerous official CDC recommendations concerning the diagnosis and treatment of disease, immunization schedules, infection control, and clinical prevention practices. CDC/ATSDR offers technical assistance and training to health professionals as well. In order to ensure that the public and other key audiences, like health care providers, understand the information, are motivated to take action, and are not offended or react negatively to the messages, it is critical to test messages and materials prior to their production and release. Currently, each CDC program developing health messages is required to submit its message development and testing activities for individual OMB review. Many CDC programs have extremely short deadlines for developing and producing health messages. Some deadlines are imposed by Congress, and others are necessitated by the time-sensitive nature of the work. Many programs cannot accommodate the time required for OMB approval, and therefore skip the message testing step altogether, or resort to testing specific portions of messages with 9 or fewer individuals. The science of health communication does not Number of activities per year Data collection Intercept and touch screen interviews ............................................. Customer Satisfaction Phone Interviews ......................................... Focus Groups .................................................................................. Web-enabled research .................................................................... Dated: February 3, 2005. Betsey Dunaway, Acting Reports Clearance Officer, Office of the Chief Science Officer, Centers for Disease Control and Prevention. [FR Doc. 05–2574 Filed 2–9–05; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Musculoskeletal Disorders, Request for Applications (RFA) OH–05–004 In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting: Name: Disease, Disability, and Injury Prevention and Control Special Emphasis VerDate jul<14>2003 16:20 Feb 09, 2005 Jkt 205001 Number of respondents per activity 64 64 64 64 Panel (SEP): Musculoskeletal Disorders, Request for Applications (RFA) OH–05–004. Times and Dates: 8 a.m.–8:30 a.m., March 22, 2005 (Open). 8:30 a.m.–5 p.m., March 22, 2005 (Closed). Place: Embassy Suites Hotels, 1900 Diagonal Road, Alexandria, VA 23114 telephone 703–684–5900. Status: Portions of the meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the review, discussion, and evaluation of applications received in response to Request for Applications OH–05– 004. Contact Person for More Information: Joan F. Karr, Ph.D., Scientific Review Administrator, Office of Extramural Programs, National Institute for Occupational Safety and Health, CDC, 1600 Clifton Road, NE., MS–D72, Atlanta, GA 30333, Telephone 404–371–5261. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 support these programmatic practices. In fact, these undesirable alternatives weaken CDC/ATSDR position as a research-based public health agency providing credible health information that people can count on and use. CDC may achieve a greater level of efficacy if it can use four routine health message development and testing methods: (1) Central Location Intercept Interviews (i.e., ‘‘shopping mall’’ interviews); (2) Customer Satisfaction Phone Interviews; (3) Focus Groups; and (4) Web-enabled research. Virtually every Center, Institute, and Office (CIO) at CDC could achieve a higher level of confidence that health messages were understandable and would provoke no unintended consequences if they were empowered to use these methods efficiently. The CDC Office of Communication therefore requests approval for renewal of the Health Message Testing System that will conduct up to 64 message testing activities per year for each of three years. If all 64 testing activities are implemented, the total estimated annualized burden is 3,000 hours. Annualized Burden Table: Number of responses per respondent 1,600 1,200 1,200 2,400 Average burden per response (in hours) 1 1 1 1 30/60 30/60 30/60 30/60 pertaining to announcements of meetings and other committee management activities, for both the CDC and the Agency for Toxic Substances and Disease Registry. Dated: February 3, 2005. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC). [FR Doc. 05–2570 Filed 2–9–05; 8:45 am] BILLING CODE 4163–19–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Occupational Exposure Risk on Reproduction/ Development, Request for Applications (RFA) OH–05–003 In accordance with section 10(a)(2) of the Federal Advisory Committee Act E:\FR\FM\10FEN1.SGM 10FEN1 7114 Federal Register / Vol. 70, No. 27 / Thursday, February 10, 2005 / Notices (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting: Name: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Occupational Exposure Risk on Reproduction/Development, Request for Applications (RFA) OH–05–003. Times and Dates: 8 a.m.–8:30 a.m., March 23, 2005 (Open). 8:30 a.m.–5 p.m., March 23, 2005 (Closed). Place: Embassy Suites Hotels, 1900 Diagonal Road, Alexandria, VA 23114 telephone 703–684–5900. Status: Portions of the meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the review, discussion, and evaluation of applications received in response to Request for Applications OH–05– 003. Contact Person for More Information: Bernadine Kuchinski, Ph.D. Scientific Review Administrator, National Institute for Occupational Safety and Health, CDC, 4676 Columbia Parkway, MS C7, Cincinnati, OH 45226, Telephone 513–533–8511. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: February 3, 2005. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC). [FR Doc. 05–2571 Filed 2–9–05; 8:45 am] BILLING CODE 4163–19–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Disease Control and Prevention Healthcare Infection Control Practices Advisory Committee (HICPAC) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Public Law 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting. Name: Healthcare Infection Control Practices Advisory Committee. Times and Dates: 8:30 a.m.–5 p.m., February 28, 2005. 8:30 a.m.–4 p.m., March 1, 2005. Place: Westin Buckhead, 3391 Peachtree Road, NE., Atlanta, Georgia 30333. Status: Open to the public, limited only by the space available. Purpose: The committee is charged with providing advice and guidance to the 16:20 Feb 09, 2005 Dated: February 4, 2005. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 05–2569 Filed 2–9–05; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES VerDate jul<14>2003 Secretary, the Assistant Secretary for Health, the Director, CDC, and the Director, National Center for Infectious Diseases (NCID), regarding (1) the practice of hospital infection control; (2) strategies for surveillance, prevention, and control of infections (e.g., nosocomial infections), antimicrobial resistance, and related events in settings where healthcare is provided; and (3) periodic updating of guidelines and other policy statements regarding prevention of healthcare-associated infections and healthcare-related conditions. Matters To Be Discussed: Agenda items will include influenza pandemic preparedness for healthcare facilities; proposed recommendations for prioritization of influenza vaccine; draft recommendations on tuberculosis infection control precautions for healthcare facilities; infection control issues in ambulatory care settings; strategies for surveillance of healthcare-associated infections and healthcare-associated adverse events; and updates on CDC activities of interest to the committee. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Harriett Lynch, Committee Management Specialist, HICPAC, Division of Healthcare Quality Promotion, NCID, CDC, 1600 Clifton Road, NE., M/S A–07, Atlanta, Georgia 30333, telephone 404/498–1182. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Jkt 205001 National Institute for Occupational Safety and Health, Safety and Occupational Health Study Section In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Public Law 92–463), the Centers for Disease Control and Prevention (CDC) announces the following committee meeting. Name: Safety and Occupational Health Study Section (SOHSS), National Institute for Occupational Safety and Health (NIOSH). Times and Dates: 8 a.m.–5 p.m., February 22, 2005. 8 a.m.–5 p.m., February 23, 2005. Place: Embassy Suites Hotel, 1900 Diagonal Road, Alexandria, Virginia, 22314, telephone 703–684–5900, fax 703–684–1403. PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 Status: Open 8 a.m.–8:15 a.m., February 22, 2005. Closed 8:15 a.m.–5 p.m., February 22, 2005. Closed 8 a.m.–5 p.m., February 23, 2005. Purpose: The Safety and Occupational Health Study Section will review, discuss, and evaluate grant application(s) received in response to the Institute’s standard grants review and funding cycles pertaining to research issues in occupational safety and health, and allied areas. It is the intent of NIOSH to support broadbased research endeavors in keeping with the Institute’s program goals. This will lead to improved understanding and appreciation for the magnitude of the aggregate health burden associated with occupational injuries and illnesses, as well as to support more focused research projects, which will lead to improvements in the delivery of occupational safety and health services, and the prevention of work-related injury and illness. It is anticipated that research funded will promote these program goals. Matters To Be Discussed: The meeting will convene in open session from 8–8:15 a.m. on February 22, 2005, to address matters related to the conduct of Study Section business. The remainder of the meeting will proceed in closed session. The purpose of the closed sessions is for the study section to consider safety and occupational health-related grant applications. These portions of the meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, Centers for Disease Control and Prevention, pursuant to Section 10(d) Pub. L. 92–463. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Price Connor, Ph.D., NIOSH Health Scientist, 1600 Clifton Road, NE., Mailstop E–20, Atlanta, Georgia 30333, telephone 404–498–2511, fax 404–498–2569. Due to programmatic issues that had to be resolved, the Federal Register notice is being published less than fifteen days before the date of the meeting. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: February 4, 2005. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 05–2568 Filed 2–9–05; 8:45 am] BILLING CODE 4163–19–P E:\FR\FM\10FEN1.SGM 10FEN1

Agencies

[Federal Register Volume 70, Number 27 (Thursday, February 10, 2005)]
[Notices]
[Pages 7113-7114]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-2571]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel: Occupational Exposure Risk on Reproduction/Development, 
Request for Applications (RFA) OH-05-003

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act

[[Page 7114]]

(Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) 
announces the following meeting:

    Name: Disease, Disability, and Injury Prevention and Control 
Special Emphasis Panel (SEP): Occupational Exposure Risk on 
Reproduction/Development, Request for Applications (RFA) OH-05-003.
    Times and Dates: 8 a.m.-8:30 a.m., March 23, 2005 (Open). 8:30 
a.m.-5 p.m., March 23, 2005 (Closed).
    Place: Embassy Suites Hotels, 1900 Diagonal Road, Alexandria, VA 
23114 telephone 703-684-5900.
    Status: Portions of the meeting will be closed to the public in 
accordance with provisions set forth in section 552b(c)(4) and (6), 
Title 5 U.S.C., and the Determination of the Director, Management 
Analysis and Services Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the review, 
discussion, and evaluation of applications received in response to 
Request for Applications OH-05-003.
    Contact Person for More Information: Bernadine Kuchinski, Ph.D. 
Scientific Review Administrator, National Institute for Occupational 
Safety and Health, CDC, 4676 Columbia Parkway, MS C7, Cincinnati, OH 
45226, Telephone 513-533-8511.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: February 3, 2005.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention (CDC).
[FR Doc. 05-2571 Filed 2-9-05; 8:45 am]
BILLING CODE 4163-19-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.